You just read:

Boston Biomedical to Highlight Data Examining Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types at ASCO 2015

News provided by

Boston Biomedical Pharma, Inc.

May 14, 2015, 02:31 ET